Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Hannah L. Williams

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0434-3900; OpenAlex author ID A5020916284. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
57
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreat… Co-author DOI 10.1200/po-25-00332↗
  2. Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-1164↗
  3. Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity. Co-author DOI 10.1158/0008-5472.can-22-3050↗
  4. Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-22-1125↗
  5. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Co-author DOI 10.1016/j.cell.2021.11.017↗
  6. Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-3141↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew J. Aguirre · 6 shared papers, 2021–2025 · strength 0.70
  2. Brian Matthew Wolpin · 6 shared papers, 2021–2025 · strength 0.70
  3. Jonathan Andrew Nowak · 6 shared papers, 2021–2025 · strength 0.70
  4. Kimberly J. Perez · 5 shared papers, 2021–2025 · strength 0.61
  5. James M. Cleary · 5 shared papers, 2021–2025 · strength 0.61
  6. Douglas Adam Rubinson · 5 shared papers, 2021–2025 · strength 0.54
  7. Andressa Dias Costa · 5 shared papers, 2021–2024 · strength 0.54
  8. Harshabad Singh · 4 shared papers, 2022–2025 · strength 0.53
  9. Srivatsan Raghavan · 4 shared papers, 2021–2025 · strength 0.50
  10. Chen Yuan · 4 shared papers, 2021–2024 · strength 0.46
  11. Thomas E. Clancy · 4 shared papers, 2021–2023 · strength 0.39
  12. Sara A. Väyrynen · 4 shared papers, 2021–2023 · strength 0.39
  13. Joseph Douglas Mancias · 3 shared papers, 2022–2025 · strength 0.37
  14. Kimmie Ng · 3 shared papers, 2021–2025 · strength 0.34
  15. David C. Linehan · 3 shared papers, 2021–2023 · strength 0.31
  16. Albert C. Koong · 3 shared papers, 2021–2023 · strength 0.31
  17. Richard Francis Dunne · 3 shared papers, 2021–2023 · strength 0.31
  18. Vicente Morales‐Oyarvide · 3 shared papers, 2021–2023 · strength 0.31
  19. Jiping Wang · 3 shared papers, 2021–2023 · strength 0.31
  20. Margaret M. Kozak · 3 shared papers, 2021–2023 · strength 0.31
  21. Daniel Tandel Chang · 3 shared papers, 2021–2023 · strength 0.31
  22. Aram F. Hezel · 3 shared papers, 2021–2023 · strength 0.31
  23. Rishi Surana · 2 shared papers, 2024–2025 · strength 0.31
  24. Brandon M. Huffman · 2 shared papers, 2024–2025 · strength 0.31
  25. Stephanie K. Dougan · 2 shared papers, 2022–2024 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.